This article reviews the latest pharmaceutical forecasts from IQVIA's Market Prognosis in the Middle East and Africa (MEA) region, identifying key trends and analyzing developments over the next five years. The analysis is based on findings from five key MEA markets (Saudi Arabia, Egypt, South Africa, United Arab Emirates and Algeria) covered by IQVIA's Market Prognosis September 2022 edition.

Please fill in your details on the left, to download the article.